Comparison of the outcome of patients protected by the wearable cardioverter defibrillator (WCD) for< 90 wear days versus≥ 90 wear days
TC Dreher, I El-Battrawy, S Roeger, SL Rosenkaimer… - in vivo, 2020 - iv.iiarjournals.org
Background/Aim: The wearable cardioverter/defibrillator (WCD) is recommended to prevent
sudden cardiac death (SCD). Guidelines suggest a 90 days' period, but prolongation of …
sudden cardiac death (SCD). Guidelines suggest a 90 days' period, but prolongation of …
The wearable cardioverter-defibrillator in a real-world clinical setting: experience in 102 consecutive patients
JW Erath, M Vamos, AS Sirat, SH Hohnloser - Clinical Research in …, 2017 - Springer
Background The wearable cardioverter-defibrillator (WCD) is used for temporary protection
of patients deemed to be at high risk for sudden death (SCD) not yet meeting indications for …
of patients deemed to be at high risk for sudden death (SCD) not yet meeting indications for …
[HTML][HTML] Wearable cardioverter defibrillator: Bridge or alternative to implantation?
J Barraud, J Cautela, M Orabona, J Pinto… - World journal of …, 2017 - ncbi.nlm.nih.gov
The implantable cardioverter-defibrillator (ICD) is effective to prevent sudden cardiac death
(SCD) in selected patients with heart disease known to be at high risk for ventricular …
(SCD) in selected patients with heart disease known to be at high risk for ventricular …
[HTML][HTML] Single-center experience with wearable cardioverter-defibrillator as a bridge before definitive ICD implantation
G Mugnai, A Lupo, F Zerbo, S Saccà… - Indian Pacing and …, 2020 - Elsevier
Background The wearable cardioverter-defibrillator (WCD) has been approved for patients
with poor left ventricular ejection fraction (LVEF) who are at risk of sudden arrhythmic death …
with poor left ventricular ejection fraction (LVEF) who are at risk of sudden arrhythmic death …
Experience with the wearable cardioverter-defibrillator in patients at high risk for sudden cardiac death
NK Wäßnig, M Günther, S Quick, C Pfluecke… - Circulation, 2016 - Am Heart Assoc
Background: This study evaluated the wearable cardioverter-defibrillator (WCD) for use and
effectiveness in preventing sudden death caused by ventricular tachyarrhythmia or …
effectiveness in preventing sudden death caused by ventricular tachyarrhythmia or …
Extended follow‐up after wearable cardioverter‐defibrillator period: the PROLONG‐II study
J Mueller‐Leisse, J Brunn, C Zormpas… - ESC Heart …, 2021 - Wiley Online Library
Aim The wearable cardioverter‐defibrillator (WCD) is used for temporary protection from
sudden cardiac death (SCD) in patients with newly diagnosed heart failure with reduced …
sudden cardiac death (SCD) in patients with newly diagnosed heart failure with reduced …
Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator …
Background—Prospective data on the safety and efficacy of the wearable cardioverter
defibrillator (WCD) in a real-world setting are lacking. The Prospective Registry of Patients …
defibrillator (WCD) in a real-world setting are lacking. The Prospective Registry of Patients …
[PDF][PDF] Wearable cardioverter-defibrillator in daily clinical practice: A single-centre experience
A Wojtaszczyk, K Kaczmarek… - Polish Heart …, 2024 - journals.viamedica.pl
Wearable cardioverter-defibrillator (WCD) is an external medical device designed to protect
patients against sudden cardiac death (SCD) due to ventricular arrhythmias. The main …
patients against sudden cardiac death (SCD) due to ventricular arrhythmias. The main …
A real world wearable cardioverter defibrillator experience–Very high appropriate shock rate in ischemic cardiomyopathy patients at a European single-center
T Beiert, R Malotki, N Kraemer, F Stoeckigt… - Journal of …, 2017 - Elsevier
Background The wearable cardioverter defibrillator (WCD) has emerged as a valuable tool
to protect patients with increased risk of sudden cardiac death (SCD). We sought to …
to protect patients with increased risk of sudden cardiac death (SCD). We sought to …
Multicenter Assessment of Wearable Cardioverter Defibrillator Use in Patients at risk of Sudden Cardiac Death: France National Experience
E Marijon, N Combes, D Gras, N Sadoul… - Circulation, 2018 - Am Heart Assoc
Hypothesis: The wearable cardioverter defibrillator (WCD) has been shown to be useful
during transient periods of high sudden cardiac death risk. This Registry was designed to …
during transient periods of high sudden cardiac death risk. This Registry was designed to …
Related searches
- wear days cardioverter defibrillator
- wear days outcome of patients
- outcome of patients cardioverter defibrillator
- icd implantation cardioverter defibrillator
- prospective registry cardioverter defibrillator
- clinical setting cardioverter defibrillator
- high risk cardioverter defibrillator
- wear days comparison of the outcome
- comparison of the outcome cardioverter defibrillator
- cardiac patients cardioverter defibrillator
- consecutive patients cardioverter defibrillator